未登录

S

Soon Kil Ahn

incheon national university

H指数:20

被引数:1,498

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

One-Pot Synthesis of 1,3,4-Oxadiazines from Acylhydrazides and Allenoates

IF4.6

2023-04-294

OAAI

Targeting Mitochondrial Oxidative Stress as a Strategy to Treat Aging and Age-Related Diseases

靶向线粒体氧化应激作为治疗衰老和年龄相关疾病的策略

IF6.6

2023-04-1520

OAAI

SJP1602, a selective and dual inhibitor of FAK and Pyk2 for treatment of triple negative breast cancer

CANCER RESEARCH

IF16.6

2020-08-151

PRE

Discrimination of Adzuki Bean (Vigna angularis) Geographical Origin by Targeted and Non-Targeted Metabolite Profiling with Gas Chromatography Time-of-Flight Mass Spectrometry

IF3.7

2020-03-1722

OAAI

Dual inhibitor of immunokinase and pan-RAF for the treatment of KRAS-mutated cancers

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Metabolite Profiling of Peppers of Various Colors Reveals Relationships Between Tocopherol, Carotenoid, and Phytosterol Content

JOURNAL OF FOOD SCIENCE

IF3.4

2017-11-1029

PREAI

Discovery of a novel pan-RAF inhibitor with potent anti-tumor activity in preclinical models of BRAFV600E mutant cancer

IF5.1

2017-08-0111

PREAI

Development of a dual inhibitor of pan-RAF and angiogenesis for the treatment of metastatic colorectal cancer with mutant K-RAS

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Development of a dual inhibitor of pan-RAF and VEGFR2 for the treatment of metastatic colorectal cancer with mutant K-RAS

CANCER RESEARCH

IF16.6

2016-07-150

PRE

A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499

IF5.1

2015-01-0110

PREAI

Oncogenic BRAF inhibitor UAI-201 induces cell cycle arrest and autophagy in BRAF mutant glioma cells

IF5.1

2014-05-0115

PREAI

Differential inhibitory effects of two Raf-targeting drugs, sorafenib and PLX4720, on the growth of multidrug-resistant cells

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2012-09-0217

PRE

Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152

IF10.1

2012-07-0118

PRE

Discovery of novel B-Raf kinase inhibitor with potent orally anticancer activity

CANCER RESEARCH

IF16.6

2012-04-010

PRE

Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents

基于结构的新型微管蛋白抑制剂的虚拟筛选及其作为抗有丝分裂剂的表征

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2010-10-0144

PRE

Identification of CKD-516: A Potent Tubulin Polymerization Inhibitor with Marked Antitumor Activity against Murine and Human Solid Tumors

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2010-08-0687

PRE

Process development and scale-up of PPAR α/γ dual agonist lobeglitazone sulfate (CKD-501)

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2007-01-2021

PREAI

Enantiomers of higenamine inhibit LPS-induced NOS in a macrophage cell line and improve the survival of mice with experimental endotoxemia

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2006-02-0137

PREAI

A stereoselective asymmetric synthesis of antibiotic (-)-fumagillol using claisen rearrangement and intramolecular ester enolate alkylation as key steps

ARCHIVES OF PHARMACAL RESEARCH

IF7.5

2005-02-014

PREAI

Synthesis and biological activity of novel substituted pyridines and purines containing 2,4-thiazolidinedione

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2004-05-01158

PREAI